Live from the NIH registry
Studies recruiting near Danbury right now
Top 25 of 1,147 recruiting studies, sorted by proximity — each links to its official registry page
International Weight Control Registry
Weight Loss, Overweight
N/A
Observational 100,000 participants sought
United States Military Academy, West Point — West Point, New York (25.2 mi)
· Sponsor: Tufts University
A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
Advanced Prostate Cancer, Metastatic Prostate Cancer
Phase 1
Interventional 210 participants sought
Yale Cancer Center — New Haven, Connecticut (28.9 mi)
· Sponsor: Genentech, Inc.
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
New York Medical College — Valhalla, New York (27.6 mi)
· Sponsor: National Cancer Institute (NCI)
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
Yale University School of Medicine — New Haven, Connecticut (28.9 mi)
· Sponsor: Medtronic MiniMed, Inc.
ACX-362E [Ibezapolstat] for Oral Treatment of Recurrent Clostridioides Difficile Infection
Clostridium Difficile Infection Recurrence
Phase 2
Interventional 20 participants sought
Gastroenterolgy Center of Conneticut — Hamden, Connecticut (29.8 mi)
· Sponsor: Acurx Pharmaceuticals Inc.
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Smilow Cancer Hospital Care Center-Trumbull — Trumbull, Connecticut (17.8 mi)
· Sponsor: SWOG Cancer Research Network
A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
N/A
Observational 30 participants sought
Yale School Of Medicine — New Haven, Connecticut (28.9 mi)
· Sponsor: Takeda
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
Hyperphosphatemia, Chronic Kidney Disease Requiring Chronic Dialysis
Phase 2
Interventional 168 participants sought
DaVita Clinical Research — Middlebury, Connecticut (19.8 mi)
· Sponsor: R1 Therapeutics
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Yale-New Haven Hospital-Yale Cancer Center — New Haven, Connecticut (28.9 mi)
· Sponsor: Relay Therapeutics, Inc.
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Acute Myeloid Leukemia (AML)
Phase 3
Interventional 1,300 participants sought
Yale University School of Medicine — New Haven, Connecticut (28.9 mi)
· Sponsor: Kura Oncology, Inc.
A Study of Buntanetap in Participants With PD
Parkinson's Disease (PD), Deep Brain Stimulation
Phase 2, Phase 3
Interventional 500 participants sought
New England Institute for Clinical Research (Ki Health Partners) — Stamford, Connecticut (24.3 mi)
· Sponsor: Annovis Bio Inc.
Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors
Solid Tumors, Sarcomas
Phase 1
Interventional 180 participants sought
Zai Lab Site 02030 — New Haven, Connecticut (28.9 mi)
· Sponsor: Zai Lab (Shanghai) Co., Ltd.
Observational Study Protocol: LIVER-R
Hepatobiliary Cancers
N/A
Observational 4,000 participants sought
Research Site — White Plains, New York (29.6 mi)
· Sponsor: AstraZeneca
A Study to Evaluate Topical ATR04-484 for EGFRi-Associated Dermal Toxicity
EGFR Inhibitor-associated Rash
Phase 1, Phase 2
Interventional 32 participants sought
Yale University School of Medicine — New Haven, Connecticut (28.9 mi)
· Sponsor: Azitra Inc.
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — New Haven, Connecticut (28.9 mi)
· Sponsor: Sameek Roychowdhury
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
Nuvance Health- Danbury Hospital — Danbury, Connecticut (1.0 mi)
· Sponsor: Duke University
Efficacy of the I-CARE Digital Health Intervention
Mental Health Disorder, Suicide Attempt
N/A
Interventional 173 participants sought
Yale — New Haven, Connecticut (28.9 mi)
· Sponsor: Dartmouth-Hitchcock Medical Center
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
N/A
Observational 3,000 participants sought
Yale University — New Haven, Connecticut (28.9 mi)
· Sponsor: Duke University
Neurologic Stem Cell Treatment Study
Neurologic Disorders, Nervous System Diseases
N/A
Interventional 500 participants sought
MD Stem Cells — Westport, Connecticut (18.9 mi)
· Sponsor: MD Stem Cells
Neuroprognostication Bias: A Collaboration to Reduce the Impact of Self-fulfilling Prophecy in Cardiac ARrEst
Cardiac Arrest
N/A
Observational 600 participants sought
Yale University — New Haven, Connecticut (28.9 mi)
· Sponsor: Boston Medical Center
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Stamford Hospital/Bennett Cancer Center — Stamford, Connecticut (24.3 mi)
· Sponsor: NRG Oncology
Building and Sustaining Exercise Habits for Adults With Type 1 Diabetes
Type 1 Diabetes (T1D), Latent Autoimmune Diabetes in Adult (LADA)
N/A
Interventional 60 participants sought
Yale School of Medicine — New Haven, Connecticut (28.9 mi)
· Sponsor: Yale University
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms
Phase 3
Interventional 450 participants sought
Yale-New Haven Hospital — New Haven, Connecticut (28.9 mi)
· Sponsor: Eli Lilly and Company
A Study to Learn How Different Amounts of the Study Medicine Called PF-08103402 Are Tolerated and Act in the Body in Healthy Adults or Adults With Mild To-moderate Asthma
Healthy Volunteer Study, Healthy Adults
Phase 1
Interventional 139 participants sought
Pfizer Clinical Research Unit - New Haven — New Haven, Connecticut (28.9 mi)
· Sponsor: Pfizer
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Smilow Cancer Hospital Care Center-Trumbull — Trumbull, Connecticut (17.8 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group